456 related articles for article (PubMed ID: 32792482)
1. A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR.
Liu H; Xu Y; Yao B; Sui T; Lai L; Li Z
Cell Death Dis; 2020 Aug; 11(8):613. PubMed ID: 32792482
[TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
Hu N; Ji H
Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine reader IMP2 stabilizes the ZFAS1/OLA1 axis and activates the Warburg effect: implication in colorectal cancer.
Lu S; Han L; Hu X; Sun T; Xu D; Li Y; Chen Q; Yao W; He M; Wang Z; Wu H; Wei M
J Hematol Oncol; 2021 Nov; 14(1):188. PubMed ID: 34743750
[TBL] [Abstract][Full Text] [Related]
5. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.
Yang D; Qiao J; Wang G; Lan Y; Li G; Guo X; Xi J; Ye D; Zhu S; Chen W; Jia W; Leng Y; Wan X; Kang J
Nucleic Acids Res; 2018 May; 46(8):3906-3920. PubMed ID: 29529255
[TBL] [Abstract][Full Text] [Related]
6. METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA.
Meng L; Lin H; Huang X; Weng J; Peng F; Wu S
Cell Death Dis; 2022 Jan; 13(1):38. PubMed ID: 35013106
[TBL] [Abstract][Full Text] [Related]
7. Dynamic N6-methyladenosine modification of lncRNA modulated by METTL3 during bacterial disease development in an echinoderm.
Zhang S; Shao Y; Li D; Li C
Fish Shellfish Immunol; 2022 May; 124():497-504. PubMed ID: 35483599
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
[TBL] [Abstract][Full Text] [Related]
9. LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC.
Qian X; Yang J; Qiu Q; Li X; Jiang C; Li J; Dong L; Ying K; Lu B; Chen E; Liu P; Lu Y
J Hematol Oncol; 2021 Jul; 14(1):112. PubMed ID: 34274028
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
Wen S; Wei Y; Zen C; Xiong W; Niu Y; Zhao Y
Mol Cancer; 2020 Dec; 19(1):171. PubMed ID: 33308223
[TBL] [Abstract][Full Text] [Related]
11. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
Hu Y; Tang J; Xu F; Chen J; Zeng Z; Han S; Wang F; Wang D; Huang M; Zhao Y; Huang Y; Zhuo W; Zhao G
J Exp Clin Cancer Res; 2022 Feb; 41(1):69. PubMed ID: 35183226
[TBL] [Abstract][Full Text] [Related]
12. RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.
Cui Y; Zhang C; Ma S; Li Z; Wang W; Li Y; Ma Y; Fang J; Wang Y; Cao W; Guan F
J Exp Clin Cancer Res; 2021 Sep; 40(1):294. PubMed ID: 34544449
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR.
Dong L; Geng Z; Liu Z; Tao M; Pan M; Lu X
Pathol Res Pract; 2021 Sep; 225():153550. PubMed ID: 34340128
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
[TBL] [Abstract][Full Text] [Related]
15. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
16. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
[TBL] [Abstract][Full Text] [Related]
17. The N
Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
[No Abstract] [Full Text] [Related]
18. Comprehensive analysis of lncRNAs N
Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
[TBL] [Abstract][Full Text] [Related]
19. LncRNA THOR acts as a retinoblastoma promoter through enhancing the combination of c-myc mRNA and IGF2BP1 protein.
Shang Y
Biomed Pharmacother; 2018 Oct; 106():1243-1249. PubMed ID: 30119193
[TBL] [Abstract][Full Text] [Related]
20. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
